For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts

Blog
The current state of pharmaceutical tariffs
Background Amid the Trump trade upheaval, pharmaceutical products receive different treatment than many other US imports. Pharmaceuticals are treated differently for reasons such as their…

DC Journal
Point: Medicaid Work Requirements Are a Common-Sense Reform
Medicaid is the government program that is supposed to help the poor afford health care. Its cost to taxpayers has skyrocketed in the last few…

Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Search Posts
Op-Eds
Sick Patients Need Cutting-Edge Drugs
The story of Anna Tomalis trying to recieve a compassionate usage exemption from the FDA to treat her cancer.
Newsletter
Drug Approval at the FDA, Childhood Obesity and the War on Bottled Water
Industry analysts characterize the Food and Drug Administration’s drug approval process as especially “conservative.” An anti-obesity advertising campaign targeted at children generates controversy. Local government…
News Release
Reform Needed at the Food and Drug Administration
Washington, D.C., August 14, 2008—In order to best serve the interests of the nation’s patients and doctors, the structure of the…
Newsletter
Global Warming Apathy, Pelosi on Oil Drilling and Government Health Care
A new survey suggests that public concern about global warming is on the decline. House Speaker Nancy Pelosi reverses her opposition to a vote on…
Study
FDA’s Bad Medicine
How the dispersed knowledge problem affects drug safety analysis and how markets and technology will help patients…
Blog
Ending the HIV Travel Ban
The federal government is finally in the process of lifting the travel ban on individuals who are HIV positive. For many years, one of…